The Long Island lefty will miss some time as there is currently no timetable set for his return to the mound.
The Mets will be relying on their starting pitching depth over the first few weeks of the season, and maybe for a little bit of time beyond. Left-hander Steven Matz spoke to the media on Monday and revealed he’s been diagnosed with a strained flexor tendon in his pitching elbow.
More from New York Mets News
- NY Mets: Trade market for starting pitchers feels non-existent
- NY Mets need to call the Athletics about a Matt Chapman trade
- NY Mets dream starting lineup for the 2022 season
- NY Mets offseason makeover might be a simple “She’s All That” situation
- NY Mets: 8 Ex-Amazins who killed it with other teams in 2021
“From my understanding, it’s like a flexor strain, I strained my flexor. That’s kind of what the feeling is, that the flexor tendon is kind of flaring up,” Matz told reporters.
Matz had been placed on the disabled list before the season officially got underway with “elbow irritation,” but this latest claim by the pitcher raises a few more concerns about his availability in the early part of the year.
According to Newsday, Matz said the plan going forward will be to rest his arm until the last week of April when he’ll start throwing again. If that goes well, this will just begin his comeback as he’ll have to build his arm strength again and work through another throwing program before being able to pitch for the big league club.
Matz is obviously annoyed by this latest development.
“I don’t think I need to say it. It’s my job. I can’t do what I love to do professionally and personally. It’s frustrating.”
Throughout his young career, Matz has had to endure injury after injury, so his durability is definitely being questioned. In our season preview, I picked Matz as the pitcher I’m looking forward to seeing the most because 2017 is going to be a make it or break it year for the lefty. If he’s unable to stay healthy for a majority of the year, the Mets may start looking elsewhere for the long-term. This latest setback will obviously not help his stock.